Taken together, our findings indicate that FGF2 differentially regulates Slug and ZEB1 expression via the PI3K/Akt/mTOR and MAPK/ERK signaling pathways in human ovarian cancer cells. This evidence concerns the gene FGF2 and ovarian carcinoma.